Knowledge base
1,260 claims across 14 domains
Every claim is an atomic argument with evidence, traceable to a source. Browse by domain or search semantically.
All 1,260ai alignment 320internet finance 259health 207space development 171entertainment 130grand strategy 101energy 23mechanisms 18collective intelligence 14manufacturing 5robotics 5critical systems 3unknown 3teleological economics 1
State Medicaid budget pressure is actively reversing GLP-1 obesity coverage gains with California and three other states eliminating coverage in 2025-2026
As of January 2026, only 13 states (26% of state programs) cover GLP-1s for obesity under fee-for-service Medicaid, but critically, four states have actively eliminated existing coverage due to budget pressure: California, New Hampshire, Pennsylvania, and South Carolina. California's Medi-Cal projec
The Medicare GLP-1 Bridge program's Low-Income Subsidy exclusion structurally denies the lowest-income Medicare beneficiaries access to GLP-1 obesity coverage despite nominal eligibility
The Medicare GLP-1 Bridge program (July-December 2026) covers Wegovy and Zepbound at a fixed $50 copayment for eligible Part D beneficiaries. However, the program contains a critical structural flaw: Low-Income Subsidy (LIS) cost-sharing subsidies will not apply to GLP-1 prescriptions filled under t
Never-skilling affects trainees while deskilling affects experienced physicians creating distinct population risks with different intervention requirements
Oettl et al. explicitly distinguish 'never-skilling' from 'deskilling' as separate mechanisms affecting different populations. Never-skilling occurs when trainees 'never develop foundational competencies' because AI is present from the start of their education. Deskilling occurs when experienced phy
Never-skilling is mechanistically distinct from deskilling because it affects trainees who lack baseline competency rather than experienced physicians losing existing skills
Oettl et al. explicitly distinguish 'never-skilling' from deskilling as separate mechanisms with different populations and dynamics. Deskilling affects experienced physicians who have baseline competency and lose it through AI reliance. Never-skilling affects trainees who never develop foundational
Audio-only telehealth is the equity-relevant modality because it over-indexes on populations that video-based telehealth systematically underserves
Among telehealth modalities, audio-only demonstrates a distinct equity profile. Medicare beneficiaries who are older, racial/ethnic minorities, dual-enrolled, rural, or have low broadband access are significantly more likely to use audio-only than video-based telehealth. This pattern inverts the typ
Culturally adapted digital mental health interventions achieve double the effect size for racial/ethnic minorities compared to standard apps
The JMIR 2024 meta-analysis found that culturally adapted digital mental health interventions achieve an effect size of g=0.90 for racial/ethnic minorities, compared to g=0.43 for standard apps—a 2.1x improvement. This suggests that the widely documented efficacy gap for digital mental health in min
Cytology lab consolidation creates never-skilling pathway through 80 percent training volume destruction
Following UK cervical screening consolidation with AI-assisted reading, case volumes reduced 80-85% while labs consolidated from 45 to 8 centers. The authors identify this as having 'major implications for training capacity.' This represents a distinct mechanism from individual cognitive deskilling:
After societies cross a material wealth threshold the primary determinant of health shifts from absolute deprivation to relative social deprivation
Richard Wilkinson identified a phase transition in the determinants of population health. Below a critical threshold of material wealth, health outcomes track GDP closely — richer societies are dramatically healthier. Above that threshold, the relationship breaks down. Among OECD countries, the long
Medicaid-accepting facilities are 25 percent less likely to offer telehealth services, reproducing in-person access disparities in digital modalities
The JMIR 2024 study found that facilities accepting Medicaid were approximately 25 percent less likely to offer telehealth services compared to non-Medicaid facilities. This creates a structural inversion where populations with the greatest need for telehealth access (Medicaid enrollees, who face tr
No peer-reviewed evidence of durable physician upskilling from AI exposure as of mid-2026
The Heudel et al. scoping review examined literature through August 2025 across colonoscopy, radiology, pathology, and cytology. Authors conclude: 'empirical studies consistently demonstrate that AI can inadvertently impair physicians' performance.' The review found NO opposing evidence — no studies
Optional-use AI deployment where clinicians form independent judgment before consulting AI may structurally prevent automation bias and deskilling mechanisms observed in mandatory-use systems
The PRAIM study deployed AI mammography screening across 12 German sites with 463,094 women and 119 radiologists using an optional-use design: radiologists made their own primary read first, then voluntarily chose whether to consult AI. This design achieved a 17.6% increase in cancer detection (6.7
WHO endorsed GLP-1s for obesity treatment in December 2025 while USPSTF maintains its 2018 recommendation excluding pharmacotherapy creating the largest international-US preventive coverage policy gap in modern history
On December 1, 2025, WHO issued a formal clinical guideline recommending GLP-1 receptor agonists (liraglutide, semaglutide) and GIP/GLP-1 dual agonists (tirzepatide) as a long-term treatment option for obesity in adults. This was designated as a 'conditional recommendation, moderate-certainty eviden
AI assistance may produce neurologically-grounded, partially irreversible skill degradation through three concurrent mechanisms: prefrontal disengagement, hippocampal memory formation reduction, and dopaminergic reinforcement of AI reliance
The article proposes a three-part neurological mechanism for AI-induced deskilling: (1) Prefrontal cortex disengagement - when AI handles complex reasoning, reduced cognitive load leads to less prefrontal engagement and reduced neural pathway maintenance for offloaded skills. (2) Hippocampal disenga
AI-induced deskilling follows a consistent cross-specialty pattern where AI assistance improves performance while present but creates cognitive dependency that degrades performance when AI is unavailable
Natali et al.'s systematic review across 10 medical specialties reveals a universal three-phase pattern: (1) AI assistance improves performance metrics while present, (2) extended AI use reduces opportunities for independent skill-building, and (3) performance degrades when AI becomes unavailable, d
Automation bias in medical imaging causes clinicians to anchor on AI output rather than conducting independent reads, increasing false-positive rates by up to 12 percent even among experienced readers
A controlled study of 27 radiologists performing mammography reads found that erroneous AI prompts increased false-positive recalls by up to 12 percentage points, with the effect persisting across experience levels. The mechanism is automation bias: radiologists anchor on AI output rather than condu
Comprehensive behavioral wraparound may enable durable weight maintenance post-GLP-1 cessation, challenging the unconditional continuous-delivery requirement
The prevailing evidence from STEP 4 and other cessation trials shows that GLP-1 benefits revert within 1-2 years of stopping medication, suggesting continuous delivery is required. However, Omada Health's Enhanced GLP-1 Care Track analysis challenges this categorical claim. Among 1,124 members who d
Dopaminergic reinforcement of AI-assisted success creates motivational entrenchment that makes deskilling a behavioral incentive problem, not just a training design problem
Most clinical AI safety discussions focus on cognitive offloading (you stop practicing) and automation bias (you trust the AI). However, the dopaminergic reinforcement element is underappreciated. AI assistance produces reliable, positive outcomes (performance improvement) that create dopaminergic r
GLP-1 access follows systematic inversion where states with highest obesity prevalence have both lowest Medicaid coverage rates and highest income-relative out-of-pocket costs
States with the highest obesity rates (Mississippi, West Virginia, Louisiana at 40%+ prevalence) face a triple barrier: (1) only 13 state Medicaid programs cover GLP-1s for obesity as of January 2026 (down from 16 in 2025), and high-burden states are least likely to be among them; (2) these states h
Medicaid coverage expansion for GLP-1s reduces racial prescribing disparities from 49 percent to near-parity because insurance policy is the primary structural driver not provider bias
Before Massachusetts Medicaid (MassHealth) expanded GLP-1 coverage for obesity in January 2024, Black patients were 49% less likely and Hispanic patients were 47% less likely to be prescribed semaglutide or tirzepatide compared to White patients (adjusted odds ratios). After the coverage expansion,
Never-skilling — the failure to acquire foundational clinical competencies because AI was present during training — poses a detection-resistant, potentially unrecoverable threat to medical education that is structurally worse than deskilling
Never-skilling is formally defined in peer-reviewed literature as distinct from and more dangerous than deskilling for three structural reasons. First, it is unrecoverable: deskilling allows clinicians to re-engage practice and rebuild atrophied skills, but never-skilling means foundational represen
The USPSTF's 2018 adult obesity B recommendation predates therapeutic-dose GLP-1 agonists and remains unupdated, leaving the ACA mandatory coverage mechanism dormant for the drug class most likely to change obesity outcomes
The USPSTF's 2018 Grade B recommendation for adult obesity covers only intensive multicomponent behavioral interventions (≥12 sessions in year 1). While the 2018 review examined pharmacotherapy, it covered only orlistat, lower-dose liraglutide, phentermine-topiramate, naltrexone-bupropion, and lorca
Wealth stratification in GLP-1 access creates a disease progression disparity where lowest-income Black patients receive treatment at BMI 39.4 versus 35.0 for highest-income patients
Among Black patients receiving GLP-1 therapy, those with net worth above $1 million had a median BMI of 35.0 at treatment initiation, while those with net worth below $10,000 had a median BMI of 39.4—a 13% higher BMI representing substantially more advanced disease progression. This reveals that str
Antidepressant discontinuation follows a continuous-treatment model with 45% relapse by 12 months but slow tapering plus psychological support achieves parity with continued medication
Network meta-analysis of 76 randomized controlled trials with over 17,000 adults in clinically remitted depression shows that antidepressant discontinuation follows a continuous-treatment pattern: relapse rates reach 34.81% at 6 months and 45.12% at 12 months after discontinuation. However, slow tap
BMI fails as a malnutrition indicator in obese HFpEF patients because sarcopenic obesity allows high body fat and low muscle mass to coexist at BMI 30-plus
Among hospitalized HFpEF patients, 32.8% are obese, yet malnutrition is present even in patients with average BMI 33 kg/m². This occurs through sarcopenic obesity—the co-occurrence of low skeletal muscle mass with increased body fat. BMI measures total body mass relative to height but cannot disting
Clinical AI introduces three distinct skill failure modes — deskilling (existing expertise lost through disuse), mis-skilling (AI errors adopted as correct), and never-skilling (foundational competence never acquired) — requiring distinct mitigation strategies for each
This systematic review identifies three mechanistically distinct pathways through which clinical AI degrades physician competence. **Deskilling** occurs when existing expertise atrophies through disuse: colonoscopy polyp detection dropped from 28.4% to 22.4% after 3 months of AI use, and experienced
Page 2 of 9